Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 known ✓ | Q9H244 | 13/20 | 0.67 |
| ▸ | P2RY2 known ✓ | P41231 | 6/20 | 0.62 |
| ▸ | ADORA1 known ✓ | P30542 | 1/20 | 0.62 |
| ▸ | P2RY4 known ✓ | P51582 | 7/20 | 0.61 |
| ▸ | P2RY6 known ✓ | Q15077 | 3/20 | 0.61 |
| ▸ | P2RY1 known ✓ | P47900 | 1/20 | 0.60 |
| ▸ | ENTPD1 | P49961 | 2/20 | 0.61 |
| ▸ | MET | P08581 | 1/20 | 0.60 |
| ▸ | HGF | P14210 | 1/20 | 0.60 |
| ▸ | CDK2 | P24941 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29462119 | 1.00 | P2RY12 (0.67) | P2RY12P2RY2ADORA1P2RY4P2RY6 | |
| SCHEMBL12172884 | 0.89 | GNG2 (0.61) | P2RY12P2RY2P2RY4P2RY6ENTPD1 | |
| SCHEMBL18493688 | 0.88 | GNG2 (0.60) | P2RY12P2RY2P2RY4P2RY6ENTPD1 | |
| SCHEMBL31616878 | 0.82 | P2RY2 (0.81) | P2RY12P2RY2P2RY4P2RY6ENTPD1 | |
| SCHEMBL3019529 | 0.81 | P2RY12 (1.00) | P2RY12P2RY2ADORA1P2RY4P2RY6 | |
| SCHEMBL29395314 | 0.81 | P2RY12 (1.00) | P2RY12P2RY2ADORA1P2RY4P2RY6 | |
| SCHEMBL30504038 | 0.81 | P2RY12 (1.00) | P2RY12P2RY2ADORA1P2RY4P2RY6 | |
| SCHEMBL3911861 | 0.80 | P2RY12 (0.68) | P2RY12P2RY2ADORA1P2RY4P2RY6 | |
| SCHEMBL1592192 | 0.79 | PHLPP2 (0.67) | P2RY12P2RY2P2RY4P2RY6ENTPD1 | |
| SCHEMBL3032350 | 0.78 | P2RY4 (0.80) | P2RY12P2RY2P2RY4P2RY6MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210308319-A1 | TRANSITION TO TRANSLUCENT SUTURES | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2021-10-07 | — | — | US | claimed |
| WO-2020028666-A1 | TRANSITION TO TRANSLUCENT SUTURES | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2020-02-06 | — | — | WO | claimed |
| US-12629345-B2 | Methods, compositions, and devices for drug / live cell microarrays | PATHAK HOLDINGS LLC (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260097181-A1 | GRADIENT ANNEALING OF POLYMERIC COMPONENTS | Access Vascular, Inc. (US) | 2026-04-09 | — | — | US | disclosed |
| US-20250237787-A1 | SILICONE BIOMEDICAL DEVICE WITH POLYMERIZABLE GLYCOSAMINOGLYCANS | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2025-07-24 | — | — | US | disclosed |
| US-20250186372-A1 | FLEXIBLE INTERCONNECTED MICROPARTICLES ARRAYS: DEVICES, METHODS, COMPOSITIONS AND APPLICATIONS | PATHAK HOLDINGS LLC | 2025-06-12 | — | — | US | disclosed |
| US-20240399110-A1 | ARTICLES COMPRISING MARKINGS AND RELATED METHODS | Access Vascular, Inc. (US) | 2024-12-05 | — | — | US | disclosed |
| US-20240399329-A1 | CROSSLINKED MULTILAYERED MATERIAL COMPOSITIONS, METHODS FOR THEIR PREPARATION AND APPLICATIONS THEREOF | PATHAK HOLDINGS LLC | 2024-12-05 | — | — | US | disclosed |
| US-20240252452-A1 | METHODS, COMPOSITIONS, AND DEVICES FOR DRUG / LIVE CELL MICROARRAYS | PATHAK HOLDINGS LLC | 2024-08-01 | — | — | US | disclosed |
| US-11992627-B2 | Articles comprising markings and related methods | Access Vascular, Inc. (US) | 2024-05-28 | — | — | US | disclosed |
| US-11969398-B2 | Methods, compositions, and devices for making sustained biodegradable implants in tissue | PATHAK HOLDINGS LLC (US) | 2024-04-30 | — | — | US | disclosed |
| US-20140284501-A1 | PROCESSING MATERIALS | XYLECO, INC. | 2014-09-25 | — | — | US | disclosed |
| US-20140287469-A1 | FILTRATION | XYLECO, INC. | 2014-09-25 | — | — | US | disclosed |
| US-20140286714-A1 | PROCESSING MATERIALS | XYLECO, INC. | 2014-09-25 | — | — | US | disclosed |
| US-20140284494-A1 | RECONFIGUREABLE PROCESSING ENCLOSURES | INC., XYLECO | 2014-09-25 | — | — | US | disclosed |
| US-20140271897-A1 | COMPOSITIONS, METHODS AND DEVICES FOR LOCAL DRUG DELIVERY | Pathak Holding, LLC (US) | 2014-09-18 | — | — | US | disclosed |
| WO-2014138545-A1 | ARRAY FOR PROCESSING MATERIALS | XYLECO, INC. (US) | 2014-09-12 | — | — | WO | disclosed |
| WO-2014138548-A1 | RECONFIGURABLE PROCESSING ENCLOSURES | XYLECO, INC. (US) | 2014-09-12 | — | — | WO | disclosed |
| WO-2014138535-A1 | FILTRATION | XYLECO, INC. (US) | 2014-09-12 | — | — | WO | disclosed |
| US-20140209093-A1 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2014-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629345-B2 | Methods, compositions, and devices for drug / live cell microarrays | SRMS, FKBP4, MYL4 | P2RY12 2383/4885P2RY2 2322/4885ADORA1 3880/4885 |
| US-20260097181-A1 | GRADIENT ANNEALING OF POLYMERIC COMPONENTS | AQP3, AQP1, ELOC | P2RY12 4055/4885P2RY2 4099/4885ADORA1 3811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.